These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16936199)

  • 1. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.
    Myint KM; Yamamoto Y; Doi T; Kato I; Harashima A; Yonekura H; Watanabe T; Shinohara H; Takeuchi M; Tsuneyama K; Hashimoto N; Asano M; Takasawa S; Okamoto H; Yamamoto H
    Diabetes; 2006 Sep; 55(9):2510-22. PubMed ID: 16936199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
    Yamamoto Y; Kato I; Doi T; Yonekura H; Ohashi S; Takeuchi M; Watanabe T; Yamagishi S; Sakurai S; Takasawa S; Okamoto H; Yamamoto H
    J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.
    Wendt TM; Tanji N; Guo J; Kislinger TR; Qu W; Lu Y; Bucciarelli LG; Rong LL; Moser B; Markowitz GS; Stein G; Bierhaus A; Liliensiek B; Arnold B; Nawroth PP; Stern DM; D'Agati VD; Schmidt AM
    Am J Pathol; 2003 Apr; 162(4):1123-37. PubMed ID: 12651605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy.
    Inagi R; Nangaku M; Miyata T
    Ann N Y Acad Sci; 2005 Jun; 1043():605-8. PubMed ID: 16037283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of grape seed proanthocyanidin extracts downregulate RAGE dependant nuclear factor- kappa BP65 expression in the hippocampus of streptozotocin induced diabetic rats.
    Xu L; Li B; Cheng M; Zhang W; Pan J; Zhang C; Gao H
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):215-24. PubMed ID: 18273752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for advanced glycation end products is a promising target of diabetic nephropathy.
    Yamamoto Y; Doi T; Kato I; Shinohara H; Sakurai S; Yonekura H; Watanabe T; Myint KM; Harashima A; Takeuchi M; Takasawa S; Okamoto H; Hashimoto N; Asano M; Yamamoto H
    Ann N Y Acad Sci; 2005 Jun; 1043():562-6. PubMed ID: 16037279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE, glomerulosclerosis and proteinuria: roles in podocytes and endothelial cells.
    D'Agati V; Yan SF; Ramasamy R; Schmidt AM
    Trends Endocrinol Metab; 2010 Jan; 21(1):50-6. PubMed ID: 19783154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells.
    Tsuji H; Iehara N; Masegi T; Imura M; Ohkawa J; Arai H; Ishii K; Kita T; Doi T
    Biochem Biophys Res Commun; 1998 Apr; 245(2):583-8. PubMed ID: 9571198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies.
    Daroux M; Prévost G; Maillard-Lefebvre H; Gaxatte C; D'Agati VD; Schmidt AM; Boulanger E
    Diabetes Metab; 2010 Feb; 36(1):1-10. PubMed ID: 19932633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
    Jensen LJ; Denner L; Schrijvers BF; Tilton RG; Rasch R; Flyvbjerg A
    J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy.
    Cocchietto M; Zorzin L; Toffoli B; Candido R; Fabris B; Stebel M; Sava G
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):587-94. PubMed ID: 18926757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.
    Tan AL; Sourris KC; Harcourt BE; Thallas-Bonke V; Penfold S; Andrikopoulos S; Thomas MC; O'Brien RC; Bierhaus A; Cooper ME; Forbes JM; Coughlan MT
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F763-70. PubMed ID: 20015941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGE-RAGE and AGE Cross-link interaction: important players in the pathogenesis of diabetic kidney disease.
    Jensen LJ; Østergaard J; Flyvbjerg A
    Horm Metab Res; 2005 Apr; 37 Suppl 1():26-34. PubMed ID: 15918107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: evaluation in megsin/receptor for advanced glycation end products/inducible nitric oxide synthase triple transgenic diabetic nephropathy mouse model.
    Ohtomo S; Ito M; Izuhara Y; Van Ypersele De Strihou C; Miyata T
    Nephrology (Carlton); 2008 Dec; 13(6):517-21. PubMed ID: 18363646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of receptors for advanced glycosylated end-products in renal disease.
    Abel M; Ritthaler U; Zhang Y; Deng Y; Schmidt AM; Greten J; Sernau T; Wahl P; Andrassy K; Ritz E
    Nephrol Dial Transplant; 1995; 10(9):1662-7. PubMed ID: 8559486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy.
    Ito T; Tanimoto M; Yamada K; Kaneko S; Matsumoto M; Obayashi K; Hagiwara S; Murakoshi M; Aoki T; Wakabayashi M; Gohda T; Funabiki K; Maeda K; Horikoshi S; Tomino Y
    Nephrology (Carlton); 2006 Feb; 11(1):29-35. PubMed ID: 16509929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
    Boor P; Celec P; Behuliak M; Grancic P; Kebis A; Kukan M; Pronayová N; Liptaj T; Ostendorf T; Sebeková K
    Metabolism; 2009 Nov; 58(11):1669-77. PubMed ID: 19608208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.
    Liu K; Xu H; Lv G; Liu B; Lee MK; Lu C; Lv X; Wu Y
    Life Sci; 2015 Feb; 123():78-85. PubMed ID: 25623853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.